Advertisement
Orthopedics
Subscribe to Orthopedics
View Sample

FREE Email Newsletter

DSM's Dyneema Purity® fiber selected for use in SpineWorks, LLC's new Universal Screw Persuader

November 2, 2011 3:52 am | News | Comments

DSM, a global leader in biomedical materials, today announced that its Dyneema Purity® ultra-high-molecular-weight-polyethylene fiber was selected for use in SpineWorks, LLC's novel Universal Screw Persuader (USP)System. The patent pending USP is a Class 1 disposable system...

Mazor Robotics Systems Guide Placement of Over 15,000 Spine Implants WorldwideMazor Robotics Systems Guide Placement of Over 15,000 Spine Implants Worldwide

November 1, 2011 9:37 pm | News | Comments

CAESAREA, Israel--(BUSINESS WIRE)--Mazor Robotics Ltd (TASE: MZOR), the pioneer in innovative surgical robots and complementary products for spine surgery, announced that its clinically proven technology has been used to guide placement of more than 15,000 spinal implants...

Spinal USA Gets FDA Approval for Two New Spinal Treatment Products

October 28, 2011 10:46 am | News | Comments

PEARL, Miss.--(BUSINESS WIRE)--Spinal USA, LLC announced today that it will introduce two new additions to the company's portfolio of spinal treatment solutions at this year's meeting of the North American Spine Society (NASS) in Chicago, IL, November 1-5.

Advertisement

SpineOvations Receives European Patent for Treatment of Ligaments and Tendons

October 27, 2011 11:55 am | News | Comments

SAN DIEGO--(BUSINESS WIRE)--SpineOvations, a San Diego-based medical technology company focused on the development of new and innovative products, announced today that it has been granted a patent in Europe for its novel injectable composition technology for treatment and repair of any ligaments and tendons in the human body.

Sensable's Freeform® 3D Organic Design System Helps Maxillofacial Surgical Teams Rebuild Faces -- and Lives -- with Better Implants

October 27, 2011 9:32 am | News | Comments

WILMINGTON, Mass.--(BUSINESS WIRE)--Sensable announced that custom facial prosthetics, custom dental and maxillofacial implants, as well as custom surgical guides, created with its Freeform® 3D modeling and design system will be spotlighted at the 2011 American Association of Maxillofacial Prosthetics annual conference...

Spineology to Unveil New Thresholdâ„¢ Minimally Invasive Pedicular Fixation System at NASS

October 27, 2011 6:28 am | News | Comments

ST. PAUL, Minn.--(BUSINESS WIRE)--Spineology Inc., the innovator in anatomy-conserving spine surgery, announced today that it will unveil its new Thresholdâ„¢ pedicular fixation system at the North American Spine Society's 2011 Annual Conference in early November.

US Orthopedic Bracing Market to Grow to Nearly $1.4 Billion by 2015

October 27, 2011 6:26 am | News | Comments

TORONTO--(BUSINESS WIRE)--According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, a growing number of injuries to the aging population combined with more active lifestyles will lead to unspectacular but steady growth in the market for orthopedic bracing devices through 2015.

Companies & Markets: Global Spinal Surgery Devices Market Forecast to Reach USD 12.6 Billion in 2017

October 25, 2011 11:17 am | News | Comments

LONDON--(BUSINESS WIRE)--Spinal Surgery Devices Market to 2017 - Motion Preserving Spinal Non-Fusion Procedures to Drive Long Term Growth. The global market for medical spinal surgery devices is forecast to reach $12.6 billion in 2017 at a CAGR of 10%.

Advertisement

K2M Continues its Momentum with Nine New Products at 2011 North American Spine Society Annual Meeting

October 25, 2011 10:40 am | News | Comments

LEESBURG, Va.--(BUSINESS WIRE)--K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced it will introduce five new products at the North American Spine Society (NASS) 26th Annual Meeting...

Million-dollar payments to surgeons raise questions

October 25, 2011 6:26 am | News | Comments

(Reuters Health) - Orthopedic surgeons have received hundreds of millions of dollars from joint implant manufacturers in recent years, according to a report released Monday. In 2007, five device makers said they had paid surgeons more than $198 million, with 43 payments exceeding $1 million.

Preetha Reddy, Managing Director, Apollo Hospitals Invited to United Nations Summit on NCDs

September 20, 2011 6:38 am | by Bio-Medicine.Org | News | Comments

NEW YORK, September 20, 2011 /- Preetha Reddy, Managing Director, Apollo Hospitals, was invited to attend the United Nations Summit at New York held by the UN General Assembly for the prevention and control of Non-Communicable Diseases. Non-communicable diseases, such as heart attacks...

Depuy Spine Announces Global Launch of First Minimally Invasive System for 3D Spine Correction

September 14, 2011 8:39 am | News | Comments

Award-Winning VIPER 3D MIS Correction Set Designed to Treat Complex Pathologies

Regado Biosciences to Present at the Annual UBS Global Life Sciences Conference in New York City

September 14, 2011 6:37 am | by Bio-Medicine.Org | News | Comments

BASKING RIDGE, N.J., Sept. 14, 2011 /- Regado Biosciences, a privately held company pioneering the development of antithrombotic aptamers with active control agents, announced that Ellen McDonald, MBA, Senior Vice President and Chief Business Officer, will be presenting at the Annual UBS...

Advertisement

Boston Scientific Names Michael F. Mahoney as Company President, Announces CEO Transition Plan

September 13, 2011 9:37 pm | by Bio-Medicine.Org | News | Comments

NATICK, Mass., Sept. 13, 2011 /- Attracting one of med-tech's most inspiring leaders, Boston Scientific Corporation (NYSE: BSX ) has named Michael Mahoney, 46, as President of the Company, effective October 17, 2011.  Mahoney, Worldwide Chairman of the Medical Device and...

Metabolic Solutions Development Company Reports Positive Top-Line Results From Phase 2a Study of Its Second Compound to Treat Type 2 Diabetes

September 8, 2011 12:37 pm | by Bio-Medicine.Org | News | Comments

KALAMAZOO, Mich., Sept. 8, 2011 /- Metabolic Solutions Development Company, LLC (MSDC) confirmed today the potential of MSDC-0602 to achieve significant glucose control in type 2 diabetes patients and increase insulin sensitivity based on preliminary analysis from its Phase 2a trial of...

West to Present at Upcoming Investor Conferences

September 7, 2011 12:39 pm | by Bio-Medicine.Org | News | Comments

LIONVILLE, Pa., Sept. 7, 2011 /- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that management will participate in two upcoming investor conferences. Management will attend the 9th Annual CL King & Associates Best Ideas Conference in New York, NY....

Transgenomic to Present at Rodman & Renshaw 13th Annual Healthcare Conference

September 7, 2011 12:39 pm | by Bio-Medicine.Org | News | Comments

OMAHA, Neb., Sept. 7, 2011 /- Transgenomic, Inc. (OTC/BB: TBIO) today announced that Craig Tuttle, President and Chief Executive Officer of Transgenomic, will be presenting at the Rodman & Renshaw 13th Annual Healthcare Conference on Tuesday, September 13th at 11:40 AM Eastern Time at...

Lupin Receives Final Approval to Market Generic Ultram® ER

August 31, 2011 11:41 am | by Bio-Medicine.Org | News | Comments

BALTIMORE, Aug. 31, 2011 /- Lupin Pharmaceuticals, Inc. (LPI) today announced that it has received final approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Tramadol Hydrochloride Extended-Release Tablets, 100, 200...

Small Town Company Thrives Against All Odds

August 31, 2011 11:40 am | by Bio-Medicine.Org | News | Comments

SIERRA MADRE, Calif., Aug. 31, 2011 /- In the quaint little town of Sierra Madre, one budding business just joined the ranks of companies such as Microsoft and Oracle. By helping hospitals all over the country, Wound Care Advantage has reached #316 on Inc. Magazine's "500" list of the...

Verathon® Introduces the Heartscape™ 3D ECG System with 80-Lead Vest in Europe; Technology Provides More Complete Data to Help Diagnose Acute Myocardial Infarction (MI)

August 19, 2011 3:48 am | by Bio-Medicine.Org | News | Comments

BOTHELL, Wash., Aug. 19, 2011 /- Verathon Inc. is pleased to introduce in Europe the Heartscape™ 3D ECG System with 80-lead vest, designed to give Emergency Department (ED) physicians, Interventional Cardiologists, and ED nurses a more complete diagnostic picture by providing a 360...

Cardium Announces Receipt of $1.1 Million in Funds from Philips' Acquisition of Innercool Therapies

August 18, 2011 5:50 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Aug. 18, 2011 /- Cardium Therapeutics (NYSE Amex: CXM ) today reported that it had received funds corresponding to the final $1.1 million payment from Royal Philips Electronics in connection with Philips' acquisition of Innercool Therapies from Cardium.  The release of...

REMEDIAL II Trial of PLC's RenalGuard® Article Published in Circulation

August 18, 2011 5:50 am | by Bio-Medicine.Org | News | Comments

MILFORD, Mass., Aug. 18, 2011 /- PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today announced that final results from the REMEDIAL II investigator-sponsored clinical trial of RenalGuard® in Italy have been published on-line in...

Levosimendan - Comprehensive Patent Search

August 17, 2011 3:43 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 17, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Levosimendan - Comprehensive patent search...

Echo Therapeutics Announces Second Quarter 2011 Financial Results

August 12, 2011 4:45 am | by Bio-Medicine.Org | News | Comments

PHILADELPHIA, Aug. 12, 2011 /- Echo Therapeutics, Inc. (Nasdaq: ECTE ), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude™ SkinPrep System for transdermal drug...

Ruby+Associates Completes Latest Mercy Health Systems Design-Build Project

August 9, 2011 7:46 am | by Bio-Medicine.Org | News | Comments

FARMINGTON HILLS, Mich., Aug. 9, 2011 /- Ruby+Associates, the constructability-focused structural engineering firm, has completed its design-build assignment for Mercy Health Systems' Willard Hospital project in Willard, OH.  Ruby acted as the engineer of record on the 105,000 sq ft...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading